[Endophthalmitis as a complication of intravitreal anti-VEGF therapy in patients with exudative age-related macular degeneration and degenerative myopia].

Anti-vascular endothelial growth factor agents, injected intravitreally, became a standard therapy for choroidal neovascularization in a course of wet age-related macular degeneration and degenerative myopia. Endophthalmitis is a very rare but the most serious complication associated with this procedure. The purpose of this paper is to present three patients with endophthalmitis following intravitreal injections of anti-VEGF agents.